Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Teijin Aims at \200 Bil. Drug Sales via M&As, JV
August 26, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 26, 2002
- BULLETIN -3-
August 26, 2002
- Alliances Make Shionogi Accelerate Pharmacogenomic Research
August 26, 2002
- Banyu to Develop Once-a-week Version for Fosamac
August 26, 2002
- Korosho Calls For Self-inspections of Reusable Medical Devices
August 26, 2002
- Kuraya Sanseido to Completely Acquire Ushioda Sangokudo
August 26, 2002
- RIKEN Clarifies Repair Mechanism of DNA Lesions
August 26, 2002
- Goodman Acquires LightLab with OCT Technology
August 26, 2002
- Suzuken Transfers Nursing Care Business in Hokkaido to Medca Japan
August 26, 2002
- Osteoporosis Treatment Should Aim at Fracture Prevention, Improvement of QOL: Society Meeting
August 26, 2002
- Daiichi to Place Priority on Expansion of US Product Line
August 26, 2002
- BUSINESS NEWS IN BRIEF
August 26, 2002
- PRESS SEMINAR
August 26, 2002
- BULLETIN -1-
August 26, 2002
- WEBSITE NEWS
August 26, 2002
- GCP Revision to Follow PAL Amendment
August 26, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
August 26, 2002
- Outline of New NDA Reviewing Institution Revealed
August 26, 2002
- Large Product Line, Reasonable Prices in Drug Stores Are Appreciated: Survey
August 26, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…